As you prepare your submission to the conference, please make note of the following details:

• All types of atopic dermatitis related research are eligible for submission.
• Abstract should address scientific questions, detail clinical observations, or contain primary scientific data.
• Encore presentations of data from previously presented research may be submitted.
• Abstracts must be submitted in Word format only.
• Abstracts must be submitted in English only.

• Please ensure that you include the title, author information including first and last name (middle initial if available), and author institution (name, city, state/province, and country)
• Titles to be in bold, sentence case. Affiliations to be designated with superscript numbers
• Please include all sections indicated below
• Please double-space
• Word Limit: 600 Words (word count does not include title, authors, author affiliations, references or disclosures)
• You may insert one (1) chart or graph. (Note: charts and graphs will be included on the RAD Website; however, they will not be included in the British Journal of Dermatology publication

The following should be completed by Thursday, April 20, 2023, at 12:00 PM ET and uploaded via the link to be provided in the email you receive with your acceptance.

1. A digital presentation of your poster in high-resolution PDF format will need to be provided.
   1. Posters may be formatted as:
      1. A conventional poster on a single slide to fit on a 16 x 9 PPT slide
2. You may also submit an optional 3-minute video presentation of your poster that will be included on the RAD website. Video presentations should be provided in MP4 format.
   1. The presenter should not be an employee of an industry sponsor.

You will receive notification by Wednesday, March 29, 2023, if your abstract has been accepted to be presented as an oral presentation. The following will be required to present during the in-person conference (oral presentations will take place throughout the program). Upon acceptance, you will be assigned a date and time. Please see below for further details.

The presenting author must:

• Agree to the Confidentiality Policy on behalf of all parties involved with the abstract and communicate this policy to all involved parties. The Confidentiality Policy applies to both standard and late-breaking data submission from the time of abstract submission.
• You will need to provide the slides for your oral presentation, or final video, along with your disclosure information, for CME approval by Monday, April 17, 2023 .
  • Oral presentations will be 7-10 minutes.
• Verify that, if necessary for the work reported, the clinical research represented in the abstract was approved by an appropriate ethics committee or institutional review board and that, if appropriate to the research, informed consent was obtained for all subjects.
• Verify that all coauthors are aware of the contents of the abstract and support its data.
• Agree, on behalf of all coauthors, to publication of the abstract in the final scientific program.
• For an abstract to be included in the final scientific program, it is mandatory for the presenting author to register for the conference and to settle payment within 72 hours of receiving the abstract acceptance. If accepted, you will receive a discount code via email.
• Agree to present the abstract if it is selected for oral presentation at the RAD Conference. This includes being present during the scheduled time of the oral session.
• Agree to list all potential conflicts of interest in the presentation if the abstract is accepted for oral presentation at the RAD Conference.
• Ensure that all coauthors meet the definition of authorship as stated by the International Committee of Medical Journal Editors.
• Enter the name of the clinical trial registry and the trial.